Nektar Therapeutics Stock Price (NASDAQ:NKTR)

Add to My Stocks
$58.33 $0.02 (0.03%) NKTR stock closing price Sep 18, 2018 (Closing)
Prev Close* : $58.31
Market Cap:
$10.06B
Day Low: $57.03
52 Week Low: $21.11
Open: $58.06
Volume: -
Day High: $59.6
52 Week High: $111.36
Dividend:
0.00

Latest Stock Market News

Latest Articles

Nektar Therapeutics News - From Partners

NKTR Stockcharts

View NKTR PE ratio, PS ratio stocks charts and compare with peers.
NKTR Chart
Note: Compare Nektar Therapeutics stock price history with the index and industry peers.

Nektar Therapeutics Valuation

PE ratio
(price earnings ratio)
11.93
PS ratio (
price to sales ratio
)
7.27
PB ratio (
price to book ratio
)
23.87

Nektar Therapeutics Returns

ROE
(return on equity)
216%

Nektar Therapeutics Financial Ratios

Asset Turnover
3.1
Receivables Turnover
108.46
Debt to Equity
0.13
Dividend Yield
0%

NKTR Industry Peers

Company Price Change (%)
Salix Pharma (SLXP)172.810 (0%)
Neurocrine Biosciences (NBIX)120.262.9 (2.47%)
Bayer Ag (BAYRY)21.460.18 (0.85%)
Merck (MRK)70.420 (0%)
Amgen (AMGN)202.341.53 (0.76%)
Bausch Health (BHC)23.811.26 (5.59%)
Baxalta (BXLT)46.020.18 (0.39%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Nektar Therapeutics Stock News - Partner Headlines

Nektar Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues307.71M165.43M230.78M200.7M148.92M
Net Income-96.69M-153.52M-81.17M-53.91M-162.01M
Total Operating Expense336.8M248.07M226.04M188.65M230.54M
View Nektar Therapeutics income statement
balance sheet20172016201520142013
Total Assets508.86M568.87M502.06M441.62M434.52M
Total Liabilities421.03M480.74M495.63M405.28M524.43M
Shareholders Equity87.82M88.12M6.42M36.33M-89.9M
View Nektar Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-37.61M7.93M-34.7M-116.42M90.58M
Net Cash from (used by) Operating Activities-80.41M-117.02M-73.08M-142M-38.52M
Increase (Decrease) in Prop Plant And Equipment-9.67M-6.39M-11.19M-9.97M-4.09M
View Nektar Therapeutics cash flow statement

Nektar Therapeutics Stock Message Board

As of last trading day, Nektar Therapeutics stock price was $58.33. The total market value as denoted by $10.06B for Nektar Therapeutics, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Nektar Therapeutics stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy NKTR stock than sell it, then Nektar Therapeutics stock price goes up. Conversely, if more investors wanted to sell NKTR stock than buy it, there would be greater supply than demand, and the stock price would fall. 1,708,245 NKTR shares were traded yesterday, and Nektar Therapeutics stock chart shows that the NKTR stock quote hit a day high of $59.6 and day low of $57.03. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Nektar Therapeutics dividend per share was 0.00 during the last quarter. Nektar Therapeutics stock price history, gives the entire historical data for NKTR stock.